Bilprevda
Product Images NDC 78206-195

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bilprevda (NDC 78206-195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pic1 Henlius Corrected Serum Calcium By Visit In Responders)

Figure 1 (Pic1   Henlius   Corrected Serum Calcium By Visit In Responders)
A line graph showing corrected calcium levels (mmol/L and mg/dL) over study days for 23 patients receiving Denosumab 120 mg. The graph plots calcium decline from baseline through day 57, with error bars indicating variability at each time point.*
FDA Label Image
Figure 2 (Pic2   Henlius   Organon Logo)
Bilprevda 20 mg tablet labeled with the proprietary name, active ingredient strength, and plain white circular appearance. The labeler shown is Organon LLC. The tablet is plain without visible markings or scoring.*
FDA Label Image

Image Description (Bilprevda 120mg Carton (2))

Image Description (Bilprevda 120mg Carton (2))
Packaging label for Bilprevda injection (denosumab-nxxp), 120 mg/1.7 mL (70 mg/mL), by Organon LLC. The label indicates the product is a sterile solution for subcutaneous use only, with no preservative, and includes storage instructions to keep refrigerated at 2°C to 8°C. The label also shows manufacturer information for Shanghai Henlius Biotech, Inc., and Organon LLC, along with barcode and dosage instructions to discard unused portions of the 1.7 mL single-dose vial.*
FDA Label Image

Image Description (Bilprevda 120mg Container Label (2))

Image Description (Bilprevda 120mg Container Label (2))
Label for Bilprevda (denosumab-nxxp) injection, 120 mg/1.7 mL (70 mg/mL) strength. The label includes the product NDC 78206-195-01 and indicates it is manufactured by Shanghai Henlius Biotech, Inc. with U.S. License No. 2354. Also shown are placeholders for lot and expiration dates, and 'Rx Only'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.